Insulin Adherence in Type 2 Diabetes in Mexico: Behaviors and Barriers

被引:27
|
作者
Bermeo-Cabrera, Janneth [1 ]
Almeda-Valdes, Paloma [1 ,2 ]
Riofrios-Palacios, Josefa [1 ]
Aguilar-Salinas, Carlos A. [1 ,2 ]
Mehta, Roopa [1 ,2 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Mexico City, DF, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Invest Enfermedades Metab, Mexico City, DF, Mexico
关键词
THERAPY; ATTITUDES;
D O I
10.1155/2018/3190849
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To investigate factors associated with insulin adherence in subjects with type 2 diabetes mellitus (T2D) attending a tertiary care centre in Mexico City. Material and Methods. Cross-sectional study, including 200 patients. Adherence to insulin therapy was measured with a medication adherence questionnaire. Sociodemographic data and factors related to insulin omission were collected and compared between the nonadherent and adherent groups. Results. We categorized 117 (58.5%) patients as nonadherent and 83 (41.5%) as adherent. Among the adherent, only 22 patients (11%) had excellent adherence to insulin therapy. The following factors were associated with nonadherence: lack of planning of daily activities (46.1%), fear of hypoglycemia (11%), economic factors (15.4%), and number of insulin applications (2.31 versus 1.76 applications per day). Conclusions. In this study, patients with type 2 diabetes attending a tertiary care referral centre showed inadequate adherence to insulin therapy. The principal factors associated with insulin omission were low socioeconomic status, fear of hypoglycemia, and a greater number of insulin applications per day.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Adherence to oral hypoglycaemic agents in type 2 diabetes: Is this a predictor of insulin requirement?
    Evans, JMM
    Dorman, PT
    Morris, AD
    DIABETOLOGIA, 2001, 44 : A36 - A36
  • [32] ADHERENCE TO INITIATED BASAL INSULIN ANALOG TREATMENT IN TYPE 1 AND 2 DIABETES
    Westerbacka, J.
    Mihailov, H.
    Valle, T.
    Jaaskelainen, S.
    Kaukua, J.
    VALUE IN HEALTH, 2015, 18 (07) : A612 - A612
  • [33] Pen devices to improve patient adherence with insulin therapy in type 2 diabetes
    Goldstein, Henry Howard
    POSTGRADUATE MEDICINE, 2008, 120 (03) : 172 - 179
  • [34] Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes
    Evans, JMM
    Donnan, PT
    Morris, AD
    DIABETIC MEDICINE, 2002, 19 (08) : 685 - 688
  • [35] Adherence to initiated basal insulin analogue treatment in type 1 and 2 diabetes
    Westerbacka, J.
    Mihailov, H.
    Valle, T.
    Jaaskelainen, S.
    Kaukua, J.
    DIABETOLOGIA, 2015, 58 : S469 - S470
  • [36] Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study
    Rezaei, Mehdi
    Valiee, Sina
    Tahan, Mohammad
    Ebtekar, Fariba
    Gheshlagh, Reza Ghanei
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 589 - 599
  • [37] A MIXED METHODS INVESTIGATION OF THE BARRIERS AND FACILITATORS TO MEDICATION ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES
    Huang, Yen-Ming
    Shiyanbola, Olayinka O.
    Pecanac, Kristen E.
    ANNALS OF BEHAVIORAL MEDICINE, 2020, 54 : S35 - S35
  • [38] Self-Reported Barriers to Adherence and Persistence for Type 2 Diabetes Injectable Treatments
    Spain, C. Victor
    Wright, Jonathon J.
    Hahn, Rebecca M.
    Martin, Alan A.
    DIABETES, 2014, 63 : A252 - A252
  • [39] A randomized trial to reduce adherence barriers and medication discrepancies in type 2 diabetes.
    Grant, RW
    Devita, NG
    Singer, DE
    Meigs, JB
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 : 195 - 195
  • [40] Barriers and strategies for oral medication adherence among children and adolescents with Type 2 diabetes
    Venditti, E. M.
    Tan, K.
    Chang, N.
    Laffel, L.
    McGinley, G.
    Miranda, N.
    Tryggestad, J. B.
    Walders-Abramson, N.
    Yasuda, P.
    Delahanty, L.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 139 : 24 - 31